Nuss John's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Jul 5, 2023
- Accession no.
- 0001209191-23-041355
- Filed
- Jul 5, 2023, 8:20 PM ET
- Trade date
- Jul 3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $791.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nuss JohnCIK 0001874108 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2023 | Common Stock | MOption exerciseAcquired | +20,000 | $0.20 | +$4,000 | 264,815 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −327 | $33.54F2 | −$10,968.95 | 264,488 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −142 | $34.72F3 | −$4,930.68 | 264,346 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −20 | $35.27 | −$705.47 | 264,326 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −2,266 | $38.32F4 | −$86,831.53 | 262,060 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −1,563 | $39.33F5 | −$61,480.29 | 260,497 | Direct | |
| Jul 3, 2023 | Common Stock | SSaleDisposed | −15,682 | $39.96F6 | −$626,720.15 | 244,815 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 26,778 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 327 shares sold in the price range of $33.28 to $34.1123. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 142 shares sold in the price range of $34.2706 to $35.2163. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average share price of an aggregate total of 2,266 shares sold in the price range of $37.9611 to $38.9601. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average share price of an aggregate total of 1,563 shares sold in the price range of $38.9668 to $39.6514. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average share price of an aggregate total of 15,682 shares sold in the price range of $39.70 to $40.0506. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.